Association between dysbiotic perio-pathogens and inflammatory initiators and mediators in COVID-19 patients with diabetes
- PMID: 38293542
- PMCID: PMC10825424
- DOI: 10.1016/j.heliyon.2024.e24089
Association between dysbiotic perio-pathogens and inflammatory initiators and mediators in COVID-19 patients with diabetes
Abstract
It has been suggested that a corona virus infection is linked to chronic periodontitis (COVID-19). Our objectives were to look at the expression of angiotensin-converting enzyme-2 (ACE2) in periodontal compartments containing periodontal infections to determine if ACE2 is directly or indirectly responsible for the inflammation in periodontal tissues getting worse. In this study, six non-COVID-19 periodontitis patients without diabetes served as controls, and 23 hospitalized periodontitis patients were admitted with PCR-confirmed COVID-19 with diabetes mellitus (Group 1/G1, n = 10), and without diabetes (Group 2/G2, n = 13). We evaluated the mRNA expression of ACE2, IL-6, IL-8, complement C3, and LL-37, as well as the relative proportion of Porphyromonas gingivalis, Fusobacterium nucleatum, and Veillonella parvula to represent the dysbiosis condition in periodontal microenvironment using subgingival plaque and gingival crevicular fluids (GCF) samples and quantitative real time PCR (qPCR). Every analysis was done to ascertain how they related to one another. The area under the curve (AUC) and receiver operating characteristic (ROC) curve were used to determine the sensitivity and specificity of inflammatory indicators. All the grouped patients had ACE2 detected, according to our findings, but only the G1 patients had a positive correlation (p < 0.05) between ACE2 expression and the inflammatory markers. The combination of IL-6 and C3 mRNAs was found to be 0.78 and 0.55 for the G1 group and the G2 group, respectively, based on the ROC and AUC values. According to our research, the relationship between complement C3 and IL-6 may be able to predict the degree of periodontal inflammation in COVID-19 patients who also have diabetes.
Keywords: ACE2; Corona virus; Diabetes; Dysbiosis; Gingival crevicular fluid; Inflammation; Periodontitis; mRNA expression.
© 2024 Published by Elsevier Ltd.
Conflict of interest statement
The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
Figures
Similar articles
-
ACE2 expression in saliva of patients with COVID-19 and its association with Candida albicans and Aggregatibacter actinomycetemcomitans.F1000Res. 2022 May 23;11:557. doi: 10.12688/f1000research.111965.2. eCollection 2022. F1000Res. 2022. PMID: 36112976 Free PMC article.
-
Porphyromonas gingivalis association with inflammatory markers and exosomal miRNA-155 in saliva of periodontitis patients with and without diabetes diagnosed with COVID-19.Saudi Dent J. 2023 Jan;35(1):61-69. doi: 10.1016/j.sdentj.2022.12.002. Epub 2022 Dec 16. Saudi Dent J. 2023. PMID: 36540394 Free PMC article.
-
PGE2, IL-1 beta, and TNF-alpha responses in diabetics as modifiers of periodontal disease expression.Ann Periodontol. 1998 Jul;3(1):40-50. doi: 10.1902/annals.1998.3.1.40. Ann Periodontol. 1998. PMID: 9722689
-
Porphyromonas Gingivalis in the Development of Periodontitis: Impact on Dysbiosis and Inflammation.Arch Razi Inst. 2022 Oct 31;77(5):1539-1551. doi: 10.22092/ARI.2021.356596.1875. eCollection 2022 Oct. Arch Razi Inst. 2022. PMID: 37123122 Free PMC article. Review.
-
Should We Be Concerned about the Association of Diabetes Mellitus and Periodontal Disease in the Risk of Infection by SARS-CoV-2? A Systematic Review and Hypothesis.Medicina (Kaunas). 2021 May 13;57(5):493. doi: 10.3390/medicina57050493. Medicina (Kaunas). 2021. PMID: 34068221 Free PMC article. Review.
References
-
- Bloomgarden Z.T. Diabetes and COVID-19. J. Diabetes. 2020;12(4):347–348. - PubMed
LinkOut - more resources
Full Text Sources
Miscellaneous